Skip to content

Clinical Trial To Study the Effect of Kantakari Churna in the Management of Mutrakruchra with Special Reference to Acute Cystitis.

A Randomized Clinical Controlled Trial To Study the Effect of Kantakari Churna in the Management of Mutrakruchra with Special Reference to Acute Cystitis. - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/05/086567
Enrollment
70
Registered
2025-05-08
Start date
Unknown
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N300- Acute cystitis

Interventions

None listed

Sponsors

Dr Harshada Rajesh Dholwade
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients with classical symptoms of mutrakruchha. 2. Ages between 18 to 50 yrs. Both sexes . 3. Patient will be included irrespective of gender, religion, socio-economic status. 4. Patient with symptoms burning micturition, painful urination, frequency,urgency, suprapubic pain

Exclusion criteria

Exclusion criteria: 1 Patients above age of 50 yrs. and below 18 yrs. 2 Patients having any type of surgery of urinary tract and medical disease of urinary system,Severe Haematuria,cathetarised patient, acute and chronic renal failure 3 Patients who are suffering with any other systemic disorders like Koch s, cancer, BPH, Hiv ,Hbsag positive 4 pregnant women and lactating women 5 k/c/o DM,HTN, IHD ,TB , Mentally ill patient

Design outcomes

Primary

MeasureTime frame
Reduction in sign and symtoms of Mutrakruchra according to Acute Cystitis Symptom Score Scale within 5days of treatmentTimepoint: 5 Days

Secondary

MeasureTime frame
nilTimepoint: nil

Countries

India

Contacts

Public ContactDr Harshada Rajesh Dholwade

SMBT Ayurved College and Hospital

adkpc74@gmail.com9689339928

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026